| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.1M | — | +161.2% |
| R&D Expense | $1.6M | — | +0.9% |
| SG&A Expense | $13.0M | — | -10.4% |
| Operating Income | -$41.8M | — | -10.8% |
| Income Tax | $0 | — | — |
| Net Income | -$33.4M | — | -478.6% |
| EPS (Basic) | -$0.21 | — | -520.0% |
| EPS (Diluted) | -$0.21 | — | -520.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90.2M | -42.4% | +301.3% |
| Accounts Receivable | $3.8M | +90.6% | +156.0% |
| Inventory | $12.3M | +31.6% | +42.1% |
| Current Assets | $146.4M | -26.1% | +194.8% |
| Total Assets | $886.0M | -4.0% | +12.5% |
| Current Liabilities | $85.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.7M | — | -9.7% |
| Capital Expenditures | $3.4M | — | -77.1% |
| Investing Cash Flow | -$20.6M | — | -37.6% |
| Financing Cash Flow | -$4.6M | — | -109.3% |
| Free Cash Flow | -$46.1M | — | +14.5% |
| -5.6% |
| Total Liabilities | $568.6M | -0.6% | +3.5% |
| Stockholders' Equity | $7.4M | -83.8% | -96.9% |